Man held in Britain over contamination of painkillers

British police arrested a man on Friday after anti-psychotic and epilepsy drugs were placed in packets of the painkiller Nurofen Plus, Scotland Yard said.

The case of suspected sabotage last month led to the makers of Nurofen Plus, Reckitt Benckiser, recalling the in Britain and halting their distribution.

A spokesman for London's Metropolitan Police Service said the unnamed 30-year-old man had been arrested in Bromley in the south of the capital on "suspicion of contamination of goods".

"The man is currently being held for questioning at a south London police station," the spokesman told AFP.

Five contaminated packets of Nurofen Plus were found in Britain in August, prompting a national and the recall by the manufacturers.

Four of the affected packs contained XL, an anti-psychotic drug used to treat schizophrenia, mania and bipolar depression, and two people accidentally took the drug but suffered no harm.

The epilepsy drug Neurontin was found in another packet but no one was thought to have taken it.

add to favorites email to friend print save as pdf

Related Stories

Dutch police investigate apparent hacker attack

Dec 10, 2010

(AP) -- Police said Friday they are investigating if hackers were responsible for taking down websites of police and prosecutors in the Netherlands after the arrest of a 16-year-old for involvement in a cyberattack on several ...

British teen arrested over CIA, US Senate hacking

Jun 21, 2011

British police working with the FBI arrested a 19-year-old man over attacks by a hacker group on businesses and government agencies including the CIA, US Senate and Sony, Scotland Yard said Tuesday.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments